z-logo
Premium
DIFFUSE LARGE B‐CELL LYMPHOMA: USING IMMUNE BIOMARKERS TO DEFINE NOVEL THERAPIES
Author(s) -
Zhao W.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.121_2629
Subject(s) - lymphoma , immune system , medicine , immunotherapy , germinal center , diffuse large b cell lymphoma , cancer research , myeloid , immunology , cancer , myeloid derived suppressor cell , b cell , antibody , suppressor

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom